Preeya K Gupta
Overview
Explore the profile of Preeya K Gupta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
1368
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bacharach J, Kannarr S, Verachtert A, Gupta P, Razeen M, Cavet M, et al.
Ophthalmol Ther
. 2025 Feb;
PMID: 39985746
Introduction: Perfluorohexyloctane ophthalmic solution (PFHO) is indicated for the treatment of signs and symptoms of dry eye disease (DED) and targets excessive tear evaporation. This study evaluated patient-reported outcomes early...
2.
Farid M, Rowen S, Moshirfar M, Cunningham D, Gaddie I, Smits G, et al.
Clin Ophthalmol
. 2024 Nov;
18:3425-3439.
PMID: 39606177
Purpose: To evaluate the efficacy of 0.2% and 0.4% pilocarpine HCl (CSF-1) for the treatment of presbyopia and to determine the contributions of pilocarpine HCl and diclofenac sodium on the...
3.
Feng Y, Venkateswaran N, Steele A, Rosenberg E, Gupta P
Clin Ophthalmol
. 2024 Oct;
18:2873-2878.
PMID: 39403710
Purpose: To evaluate the impact of TearCare (TC) treatment on clinical, quality of life, and functional visual outcome metrics in patients with dry eye disease (DED) and meibomian gland disease...
4.
Gupta P, Karpecki P
Cornea
. 2024 Oct;
44(1):128-135.
PMID: 39383472
The clinical value of upper eyelid meibographic imaging remains relatively underexplored; consequently, it is not commonly used in clinical assessments. However, its significance could be particularly important for the early...
5.
Gupta P, Toyos R, Sheppard J, Toyos M, Mah F, Bird B, et al.
Clin Ophthalmol
. 2024 Aug;
18:2283-2302.
PMID: 39165367
Dry eye disease (DED) is a common, multifactorial ocular disease impacting 5% to 20% of people in Western countries and 45% to 70% in Asian countries. Despite the prevalence of...
6.
Galor A, Britten-Jones A, Feng Y, Ferrari G, Goldblum D, Gupta P, et al.
Ocul Surf
. 2024 Jan;
32:104.
PMID: 38280516
No abstract available.
7.
Yeu E, Berdahl J, Gupta P, Patterson M
J Cataract Refract Surg
. 2024 Jan;
50(5):481-485.
PMID: 38192061
Purpose: To evaluate the sensitivity and specificity of swept-source optical coherence tomography (SS-OCT) biometer compared with the gold standard spectral-domain optical coherence tomography (SD-OCT) for detecting macular pathology in patients...
8.
Galor A, Britten-Jones A, Feng Y, Ferrari G, Goldblum D, Gupta P, et al.
Ocul Surf
. 2023 Apr;
28:262-303.
PMID: 37054911
Many factors in the domains of mental, physical, and social health have been associated with various ocular surface diseases, with most of the focus centered on aspects of dry eye...
9.
Ayres B, Donnenfeld E, Farid M, Gaddie I, Gupta P, Holland E, et al.
Eye (Lond)
. 2023 Mar;
37(15):3249-3255.
PMID: 36964261
Background: Twelve ocular surface disease experts convened to achieve consensus about Demodex blepharitis (DB) using a modified Delphi panel process. Methods: Online surveys were administered using scaled, open-ended, true/false, and...
10.
Farid M, Ayres B, Donnenfeld E, Gaddie I, Gupta P, Holland E, et al.
Clin Ophthalmol
. 2023 Mar;
17:667-679.
PMID: 36875531
Purpose: To obtain consensus on blepharitis (DB) treatment using a modified Delphi panel process. Methods: Literature search identified gaps in knowledge surrounding treatment of DB. Twelve ocular surface disease experts...